Meraya Abdulkarim M, Kashan Syed Nabeel, Syed Mamoon H, Yasmeen Ayesha, Alfaifi Mohammed H, Alfaifi Aseel J, Hurubi Khalid Y, Khobrani Moteb A, Alhossan Abdulaziz
Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan P.O Box 114-45124, Saudi Arabia.
Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan P.O Box 114-45124, Saudi Arabia.
Saudi Pharm J. 2023 Dec;31(12):101846. doi: 10.1016/j.jsps.2023.101846. Epub 2023 Oct 26.
Lockdown measures implemented during the initial phase of the pandemic resulted in the delay and disruption of healthcare utilization for individuals with chronic conditions. We aimed to evaluate the impact of COVID-19 movement restrictions on the follow-up care visits of individuals with chronic illnesses. We also assessed the possible reasons patients missed their follow-ups and the potential barriers impeding follow-up during the pandemic.
A total of 397 adults with pre-existing medical conditions participated in an online cross-sectional survey from October to December 2022. The study sample comprised 57 % females and 43 % males, with a mean age of 43 years. A 36-item online self-report survey was used for data collection. Fifty-five percent of participants reported missing their follow-up during COVID-19 pandemic, and 14 % made emergency department visits due to their missed follow-up appointments. In addition, 24 % experienced complications due to their missed appointments. The mean score on the fear of COVID-19 scale was 17.8 ± 6.5 (SD). For the majority of participants (60 %), pandemic-related restrictions were the predominant barrier to their follow-up visits. Additionally, we found that as individuals' COVID-19 fear scores increased, the likelihood of missing a follow-up care visit also increased (AOR: 1.067; p-value = 0.001). However, participants who did not perceive COVID-19 pandemic-related restrictions as a barrier were less likely to miss their follow-up visits (AOR: 0.581; p-value = 0.031). Furthermore, those who understood the significance of follow-up care were less likely to miss any of their follow-up visits (AOR: 0.224; p-value < 0.001) than those who had limited understanding of its importance.
The results showed that pandemic-related movement restrictions negatively affected attendance at follow-up visits for people with pre-existing health conditions. Initiatives should therefore be undertaken during global public health emergencies to provide medical and psychological support to vulnerable and high-risk groups.
疫情初期实施的封锁措施导致慢性病患者的医疗服务利用出现延迟和中断。我们旨在评估新冠疫情防控措施对慢性病患者后续随访就诊的影响。我们还评估了患者错过随访的可能原因以及疫情期间阻碍随访的潜在障碍。
2022年10月至12月,共有397名患有基础疾病的成年人参与了一项在线横断面调查。研究样本中女性占57%,男性占43%,平均年龄为43岁。使用一份包含36个条目的在线自填式调查问卷进行数据收集。55%的参与者报告在新冠疫情期间错过了随访,14%的参与者因错过预约随访而前往急诊科就诊。此外,24%的参与者因错过预约而出现并发症。对新冠疫情恐惧量表的平均得分为17.8±6.5(标准差)。对于大多数参与者(60%)而言,与疫情相关的限制是他们进行随访就诊的主要障碍。此外,我们发现,随着个体对新冠疫情恐惧得分的增加,错过随访就诊的可能性也增加(比值比:1.067;p值=0.001)。然而,那些不认为与新冠疫情相关的限制是障碍的参与者错过随访就诊的可能性较小(比值比:0.581;p值=0.031)。此外,那些理解随访护理重要性的参与者比那些对其重要性理解有限的参与者更不容易错过任何一次随访就诊(比值比:0.224;p值<0.001)。
结果表明,与疫情相关的防控措施对患有基础疾病人群的随访就诊率产生了负面影响。因此,在全球突发公共卫生事件期间应采取措施,为弱势群体和高危人群提供医疗和心理支持。